Head-To-Head Contrast: Novartis (NYSE:NVS) and American Brivision (Holding) (NYSE:ABVC)

Novartis (NYSE:NVS) and American Brivision (Holding) (OTCMKTS:ABVC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability. Analyst Ratings This is a summary of recent ratings for Novartis and American Brivision ...

Novartis (NYSE:NVS) and American Brivision (Holding) (OTCMKTS:ABVC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Analyst Ratings

This is a summary of recent ratings for Novartis and American Brivision (Holding), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score

Novartis21502.38

American Brivision (Holding)0000N/A

Novartis currently has a consensus target price of $91.67, suggesting a potential downside of 6.24%. Given Novartis' higher possible upside, analysts plainly believe Novartis is more favorable than American Brivision (Holding).

Insider and Institutional Ownership

10.6% of Novartis shares are owned by institutional investors. 0.0% of Novartis shares are owned by company insiders. Comparatively, 49.6% of American Brivision (Holding) shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Novartis and American Brivision (Holding)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio

Novartis$47.50 billion4.72$11.73 billion$5.2418.66

American Brivision (Holding)N/AN/AN/AN/AN/A

Novartis has higher revenue and earnings than American Brivision (Holding).

Profitability

This table compares Novartis and American Brivision (Holding)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets

Novartis24.73%23.39%9.91%

American Brivision (Holding)N/AN/A-40.35%

Risk and Volatility

Novartis has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, American Brivision (Holding) has a beta of -0.08, meaning that its stock price is 108% less volatile than the S&P 500.

Summary

Novartis beats American Brivision (Holding) on 8 of the 9 factors compared between the two stocks.